LIA
ABBV icon

LifePlan Investment Advisors’s AbbVie ABBV Stock Holding History

LifePlan Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$760K Buy
3,021
+71
+2% +$15.3K 0.26% 83
2026
Q1 		$642K Sell
2,950
-271
-8% -$60.1K 0.25% 81
2025
Q4 		$736K Buy
3,221
+248
+8% +$56.5K 0.3% 70
2025
Q3 		$688K Buy
2,973
+336
+13% +$68.4K 0.29% 69
2025
Q2 		$489K Buy
2,637
+4
+0.2% +$743 0.24% 71
2025
Q1 		$552K Buy
+2,633
New +$512K 0.32% 67

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LifePlan Investment Advisors's ABBV Position: Q2 2026 in Review

LifePlan Investment Advisors increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $15.3K and bringing the position to 3,021 shares worth $760K. The position accounts for 0.26% of the portfolio, ranked #83.

LifePlan Investment Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LifePlan Investment Advisors held 3,021 shares of AbbVie worth $760K as of Q2 2026.
  • LifePlan Investment Advisors bought 71 AbbVie shares in Q2 2026, an estimated $15.3K.
  • AbbVie made up 0.26% of LifePlan Investment Advisors's portfolio in Q2 2026, its #83 holding.
  • LifePlan Investment Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LifePlan Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.